Regulatory Expertise Leverage Dow Pharmaceutical Sciences’ deep regulatory and CMC know-how, including experience with FDA interactions, multiple NDAs, and a high volume of INDs, to position services as a strategic support for clients seeking faster and smoother approvals.

Specialized Formulations Target pharmaceutical companies needing expert semi-solid and liquid formulation development, with emphasis on stability, scalability, disease compatibility, and skin penetration to address common development bottlenecks.

Clinical & Non-Clinical Support Offer end-to-end support highlighting Dow’s familiarity with both non-clinical and clinical requirements to reduce agency query cycles and de-risk regulatory timelines for prospective clients.

LeanScale Partnerships Position as a nimble, specialized partner for mid-sized pharma and biotech firms seeking high-quality formulation development without the overhead of large CROs, aligned with Dow’s 51-200 employee footprint.

Proof of Success Highlight track record of over 40 approved INDs in 7 years and recent formulation projects for more than 75 clients to build credibility and trigger interest from sponsors aiming to accelerate reformulations or new indications.